Skip to main content
SpringerLink
Log in

Lung

  • Chapter
Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy

Abstract

Stereotactic radiotherapy for early-stage lung cancers has been widely adopted into practice, with favorable results from numerous randomized trials and large institutional series, in both inoperable and otherwise operable patient populations. Current studies seek to further optimize treatment parameters to maximize tumor ablation and minimize toxicity as definitive therapy for early-stage disease and as adjuvant therapy in locally advanced lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Altorki NK, Yip R, Hanaoka T, Bauer T, et al. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg. 2014;147(2):754–62.

    Article  PubMed  Google Scholar 

  • Badiyan SN, Bierhals AJ, Olsen JR, Creach KM, et al. Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcinoma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis. Radiat Oncol. 2013;8:4.

    Article  PubMed Central  PubMed  Google Scholar 

  • Baker R, Han G, Sarangkasiri S, DeMarco M, et al. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. Int J Radiat Oncol Biol Phys. 2013;85(1):190–5.

    Article  PubMed  Google Scholar 

  • Baumann P, Nyman J, Hoyer M, Weinberg B, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009;27(20):3290–6.

    Article  PubMed  Google Scholar 

  • Baschnagel AM, Mangona VS, Robertson JM, Welsh RJ, et al. Lung metastases treated with image-guided stereotactic body radiation therapy. Clin Oncol. 2013;25(4):236–41.

    Article  CAS  Google Scholar 

  • Benedict SH, Yenice KM, Followill D, Galvin JM, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37(8):4078–101.

    Article  PubMed  Google Scholar 

  • Bogart JA, Hodgson L, Seagren SL, Blackstock AW, et al. Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. J Clin Oncol. 2010;28(2):202–6.

    Article  PubMed Central  PubMed  Google Scholar 

  • Bollneni VR, Widder J, Pruim J, Langendijk JA, Wiegman EM. Residual 18F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control. Int J Radiat Oncol Biol Phys. 2012;83(4):e551–5.

    Article  Google Scholar 

  • Bouihol G, Ayadi M, Rit S, Thengumpallil S, Vandemeulebroucke J, et al. Is abdominal compression useful in lung stereotactic body radiation therapy? A 4DCT and dosimetric lobe-dependent study. Phys Med. 2012;29(4):333–40.

    Article  Google Scholar 

  • Bradley JD1, El Naqa I, Drzymala RE, Trovo M, et al.Stereotactic body radiation therapy for early-stage nonsmall-cell lung cancer: the pattern of failure is distant.IJROBP. 2010;77(4):1146–50.

    Google Scholar 

  • Burdick MJ, Stephans KL, Reddy CA, Djemil T, et al. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78(4):1033–9.

    Article  PubMed  Google Scholar 

  • Campeau MP, Herschtal A, Wheeler G, Mac Manus M, et al. Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009;74(5):1371–5.

    Article  PubMed  Google Scholar 

  • Casiraghi M, De Pas T, Maisonneuve P, Brambilla D, et al. A 10-year single-center experience on 708 lung metastasectomies: the evidence of the “international registry of lung metastases”. J Thorac Oncol. 2011;6(8):1373–8.

    Article  PubMed  Google Scholar 

  • Chang JY, Liu H, Balter P, Komaki R, et al. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol. 2012;7:152.

    Article  PubMed Central  PubMed  Google Scholar 

  • Chi A, Liao Z, Nguyen NP, Xu J, et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol. 2010;94:1–11.

    Article  PubMed  Google Scholar 

  • Crabtree TD, Denlinger CE, Meyers BF, El Naga I, et al. Stereotactic body radiotherapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2010;140(2):377–86.

    Article  PubMed  Google Scholar 

  • Curran Jr WJ, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst. 2011;103:1452–60.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Dahele M, Palma D, Lagerwaard F, Slotman B, Senan S. Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol. 2011;6(7):1221–8.

    Article  PubMed  Google Scholar 

  • Diot Q, Kavanagh B, Schefter T, Gaspar L, et al. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors. Int J Radiat Oncol Biol Phys. 2012;84(4):1024–30.

    Article  PubMed  Google Scholar 

  • Douillard JY, Rosell R, De Lena M, Carpagnano F, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Associated [ANITA]): a randomized control trial. Lancet Oncol. 2006;7(9):719–27.

    Article  CAS  PubMed  Google Scholar 

  • Ernst-Stecken A, Lambrecht U, Mueller R, Sauer R, Grabenbauer G. Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study. Strahlenther Onkol. 2006;182:696–702.

    Article  PubMed Central  PubMed  Google Scholar 

  • Farikis AJ, McGarry RC, Yiannoutsos CT, Papiez L, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys. 2009;75(3):677–82.

    Article  Google Scholar 

  • Feddock J, Arnold SM, Shelton BJ, Sinha P, et al. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2013;85(5):1325–31.

    Article  PubMed  Google Scholar 

  • Finlayson E, Fan Z, Birkmeyer JD. Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg. 2007;205(6):729–34.

    Article  PubMed  Google Scholar 

  • Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615–22.

    Article  CAS  PubMed  Google Scholar 

  • Griffieon GH, Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery. Radiother Oncol. 2013;107(3):403–8.

    Article  Google Scholar 

  • Grills IS, Hope AJ, Guckenberger M, Kestin LL, et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol. 2012;7(9):1382–93.

    Article  PubMed  Google Scholar 

  • Grills IS, Mangona VS, Welsh R, Chmielewski G, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28(6):928–35.

    Article  PubMed  Google Scholar 

  • Hamamoto Y, Kataoka M, Yamashita M, Shinkai T, et al. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer. Jpn J Clin Oncol. 2009;40(2):125–9.

    Article  PubMed  Google Scholar 

  • Henderson MA, Hoopes DJ, Fletcher JW, Lin PF, et al. A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010;76(3):789–95.

    Article  PubMed Central  PubMed  Google Scholar 

  • Hocking WG, Hu P, Oken MM, Winslow SD, et al. Lung cancer screening in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. J Natl Cancer Inst. 2010;102(10):722–31.

    Article  PubMed Central  PubMed  Google Scholar 

  • Hoppe BS, Laser B, Kowalski AV, Fontenla SC, et al. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small cell lung cancer: who’s at risk? Int J Radiat Oncol Biol Phys. 2008;72(5):1283–6.

    Article  PubMed  Google Scholar 

  • Hurkmans CW, Cujpers JP, Lagerwaad FJ, Widder J, et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomized phase III ROSEL study. Radiat Oncol. 2009;4(12):1.

    Article  PubMed Central  PubMed  Google Scholar 

  • Jeremic B, Videtic GM. Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer: a review. Int J Radiat Oncol Biol Phys. 2011;80(4):969–77.

    Article  PubMed  Google Scholar 

  • Johnson J, Braunstein S, Descovich M, Chuang C, et al. SBRT treatment of central chest lesions: experience at the University of California. San Francisco: University of California; 2014.

    Google Scholar 

  • Karam SD, Horne ZD, Hong RL, McRae D, et al. Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer. Radiat Oncol. 2013;8:179.

    Article  PubMed Central  PubMed  Google Scholar 

  • Kelly P, Balter PA, Rebueno N, Sharp HJ, et al. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. University of California. 2010;78(5):1387–93.

    Google Scholar 

  • Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70(3):685–92.

    Article  PubMed  Google Scholar 

  • Le QT, Loo BW, Ho A, Cotrutz C, et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006;1:802–9.

    Article  PubMed  Google Scholar 

  • Lee S, Choi EK, Park JH, Ahn SD, et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer. 2003;40:309–15.

    Article  PubMed  Google Scholar 

  • Liu H, Zhang X, Vinogradskiy YY, Swisher SG, et al. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Int J Radiat Oncol Biol Phys. 2012;84:1017–23.

    Article  PubMed Central  PubMed  Google Scholar 

  • Martini N, Bains MS, Burt ME, Zakowski MR, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109(1):120–9.

    Article  CAS  PubMed  Google Scholar 

  • Modh A, Rimmer A, Shah M, Foster A, et al. Survival and toxicity after stereotactic body radiation therapy for central lung tumors. Int J Radiat Oncol Biol Phys. 2013;87(2S):S33.

    Article  Google Scholar 

  • Mutter RW, Liu F, Abreu A, York E, et al. Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. Int J Radiat Oncol Biol Phys. 2012;82(5):1783–90.

    Article  PubMed Central  PubMed  Google Scholar 

  • Nagata Y, Hiroka M, Shibata T, Onishi H, et al. Stereotactic body radiation therapy for T1N0M0 non-small cell lung cancer: first report for inoperable population of a phase II trial by Japan Clinical Oncology Group (JCOG 0403). Int J Radiat Oncol Biol Phys. 2012;84(3):S46.

    Article  Google Scholar 

  • Nagawara K, Aoki Y, Tago M, Terahara A, Ohtomo K. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys. 2000;48:449–57.

    Article  Google Scholar 

  • Narabayashi M, Mizowaki T, Matsuo Y, Nakamura M, et al. Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors. J Radiat Res. 2012;53(5):777–84.

    Article  PubMed Central  PubMed  Google Scholar 

  • Newman AM, Bratman SV, To J, Wynne JF, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med. 2014;20(5):548–54.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Norihisa Y, Nagata Y, Takayama K, Matsuo Y, et al. Stereotactic body radiotherapy for oligometastatic tumors. Int J Radiat Oncol Biol Phys. 2008;72(2):398–403.

    Article  PubMed  Google Scholar 

  • NSCLC Meta-analyses Collaborative Group. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet. 2010;375(9722):1267–77.

    Article  PubMed Central  Google Scholar 

  • NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet. 2014;383(9928):1561–71.

    Article  PubMed Central  Google Scholar 

  • Olsen JR, Robinson CG, El Naga I, Creach KM, et al. Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;81(4):e299–303.

    Article  PubMed  Google Scholar 

  • Onishi H, Yoshiyuki S, Yasuo M, Kenji T, et al. Japanese multi-institutional study of stereotactic body radiation therapy for more than 2000 patients with stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;87(2S):S59.

    Google Scholar 

  • Onishi H, Araki T, Shirao H, Nagata Y, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101:1623–31.

    Article  PubMed  Google Scholar 

  • Onishi H, Shirato H, Nagata Y, Hiroka M, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2(7S):94–100.

    Article  Google Scholar 

  • Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys. 2012;82(3):1149–56.

    Article  PubMed  Google Scholar 

  • Peulen H, Karlsson K, Lindberg K, Tullgren O, et al. Toxicity after reirradiation of pulmonary tumors with stereotactic body radiotherapy. Radiother Oncol. 2011;101(2):260–6.

    Article  PubMed  Google Scholar 

  • Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung Adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26(1):3552–9.

    Article  PubMed  Google Scholar 

  • Pisters KM, Vallieres E, Crowley JJ, Franklin WA, et al. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.

    Google Scholar 

  • Reyngold M, Wu A, McLane A, Zhang Z, et al. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiotherapy (SBRT). Radiat Oncol. 2013;8:99.

    Article  PubMed Central  PubMed  Google Scholar 

  • RTOG. Seamless Phase I/II Study of Stereotactic Lung Radiotherapy (SBRT) for Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) in Medically Inoperable Patients: RTOG 0813. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0813

  • Rusthoven KE, Kavanagh BD, Burri SH, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol. 2009;27:1579–84.

    Article  PubMed  Google Scholar 

  • Ru Zhao Y, Xie X, de Koning HJ, Mali WP, et al. NELSON lung cancer screening study. Cancer Imaging. 2011;11:S79–84.

    Article  PubMed  Google Scholar 

  • Senthi S, Haasbeek CJ, Lagerwaard FJ, Verbakel WF, et al. Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes. J Thorac Dis. 2013;5(2):116–22.

    PubMed Central  PubMed  Google Scholar 

  • Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Lancet Oncol. 2012;13(8):802–9.

    Article  PubMed  Google Scholar 

  • Seppenwoodle Y, Shirato H, Kitamura K, Shimizu S, et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys. 2002;53(4):822–34.

    Article  Google Scholar 

  • Shah A, Hahn SM, Stetson RL, Friedberg JS, et al. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. Cancer. 2013a;119(17):3123–32.

    Article  PubMed  Google Scholar 

  • Shah C, Kestin LL, Hope AJ, Bissonnette JP, et al. Required target margins for image-guided lung SBRT: assessment of target position intrafraction and correction residuals. Pract Radiat Oncol. 2013b;3(1):67–73.

    Article  PubMed  Google Scholar 

  • Shibamoto Y, Baba F, Hashizume C, Ayakawa S, et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: 5-year mature results. Int J Radiat Oncol Biol Phys. 2013;87(2S):S34–5.

    Article  Google Scholar 

  • Shibamoto Y, Hashizume C, Baba F, Ayakawa S, et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study. Cancer. 2012;118(8):2078–84.

    Article  PubMed  Google Scholar 

  • Shirvani SM, Jiang J, Chang JY, Welsch JW, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012;84(5):1060–70.

    Article  PubMed Central  PubMed  Google Scholar 

  • Singh D, Chen Y, Hare MZ, Usuki KY, et al. Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to lung. J Thorac Dis. 2014;6(4):369–74.

    PubMed Central  PubMed  Google Scholar 

  • Stanic S, Paulus R, Timmerman RD, Michalski JM, et al. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early-stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. Int J Radiat Oncol Biol Phys. 2014;88(5):1092–9.

    Article  PubMed Central  PubMed  Google Scholar 

  • Stephans KL, Djemil T, Reddy CA, Gajdos SM, et al. A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience. J Thorac Oncol. 2009;4(8):976–82.

    Article  PubMed  Google Scholar 

  • Strauss GM, Hemdon JE, Maddus MA, Johnstone DW, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol. 2008;26(31):5043–51.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Takeda A, Kunieda E, Takeda T, Tanaka M, et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2007;70(4):1057–65.

    Article  PubMed  Google Scholar 

  • Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, et al. Lung cancer risk prediction: prostate, lung, colorectal, and ovarian cancer screening trial models and validation. J Natl Cancer Inst. 2011;103:1058–68.

    Article  PubMed Central  PubMed  Google Scholar 

  • Taremi M, Hope A, Dahele M, Pearson S, et al. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. Int J Radiat Oncol Biol Phys. 2012;82(2):967–73.

    Article  PubMed  Google Scholar 

  • The International Registry of Lung Metastases. Long term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113(1):37–49.

    Article  Google Scholar 

  • The National Lung Screening Trial Research Team. Reduced lung-cancer screening mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409.

    Article  PubMed Central  Google Scholar 

  • The National Lung Screening Trial Research Team. Results of low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013;368:1980–91.

    Article  PubMed Central  Google Scholar 

  • Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205–16.

    Article  CAS  PubMed  Google Scholar 

  • Timmerman R, Paulus R, Galvin J, Michalski J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Timmerman R, McGarry R, Yiannoutsos C, Papiez L, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24(30):4833–9.

    Article  PubMed  Google Scholar 

  • Timmerman R, Paulus R, Pass HI, Gore E, et al. RTOG 0618: Stereotactic body radiotherapy (SBRT) to treat operable early-stage lung cancer patients. J Clin Oncol. 2013, abstract #7523.

    Google Scholar 

  • Trakul N, Harris JP, Le QT, Hara WY, et al. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol. 2012a;7:1462–5.

    Article  PubMed  Google Scholar 

  • Trakul N, Chang CN, Harris J, Chapman C, et al. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors. Int J Radiat Oncol Biol Phys. 2012b;84(1):231–7.

    Article  PubMed  Google Scholar 

  • Trovo M, Linda A, El Naga I, Javidan-Nejad C, Bradley J. Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer. 2010;69(1):77–85.

    Article  PubMed  Google Scholar 

  • Uematsu M, Shioda A, Suda A, Fukui T, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys. 2001;51:666–70.

    Article  CAS  PubMed  Google Scholar 

  • Van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, et al. Management of lung nodules detected by volume CT screening. N Eng J Med. 2009;361(23):2221–9.

    Article  Google Scholar 

  • Videtic GM, Hu C, Singh A, Chang JY, et al. Radiation Therapy Oncology Group (RTOG) protocol 0915: a randomized phase 2 study comparing 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;87(2S):3.

    Article  Google Scholar 

  • Wender R, Fontham ET, Barrera E, Coldtz GA, et al. American Cancer Society lung screening guidelines. CA Cancer J Clin. 2013;63(2):107–17.

    Article  PubMed Central  PubMed  Google Scholar 

  • Wisnivesky JP, Bonomi M, Henschke C, et al. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest. 2005;128:1461–7.

    Article  PubMed  Google Scholar 

  • Wisnivesky JP, Henschke CI, Swanson S, Yankelevitz DF, et al. Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg. 2010;251:550–64.

    Article  PubMed  Google Scholar 

  • Wulf J, Haedinger U, Oppitz U, Thiele W, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60(1):186–96.

    Article  PubMed  Google Scholar 

  • Xiao Y, Papiez L, Paulus R, Timmerman R, et al. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009;73(4):1235–42.

    Article  PubMed Central  PubMed  Google Scholar 

  • Yamashita H, Nakagawa K, Nakamura N, Koyanagi H, et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol. 2007;2:21.

    Article  PubMed Central  PubMed  Google Scholar 

  • Zhuang T, Djemil T, Qi P, Magnelli A, et al. Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy. J Appl Clin Med Phys. 2013;14(2):4011.

    PubMed  Google Scholar 

  • Zimmermann FB, Geinitz H, Schill S, Grosu A, et al. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer. Lung Cancer. 2005;48(1):1. -7-14.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of California, San Francisco, 1600 Divisadero Street, Suite H1031, San Francisco, CA, 94143, USA

    Steve E. Braunstein, Sue S. Yom & Alexander R. Gottschalk

Authors
  1. Steve E. Braunstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sue S. Yom
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexander R. Gottschalk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steve E. Braunstein .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University of California, San Francisco, San Francisco, California, USA

    Rajni A. Sethi

  2. Departments of Radiation Oncology & Neurological Surgery, University of California, San Francisco, San Francisco, California, USA

    Igor J. Barani

  3. Department of Radiation Oncology and Urology, University of California, San Francisco, San Francisco, California, USA

    David A. Larson

  4. Department of Radiation Oncology and Urology, University of California, San Francisco, San Francisco, California, USA

    Mack Roach, III

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Braunstein, S.E., Yom, S.S., Gottschalk, A.R. (2016). Lung. In: Sethi, R., Barani, I., Larson, D., Roach, III, M. (eds) Handbook of Evidence-Based Stereotactic Radiosurgery and Stereotactic Body Radiotherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-21897-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-21897-7_7

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-21896-0

  • Online ISBN: 978-3-319-21897-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation